Clinical Rheumatology

, Volume 15, Issue 5, pp 473–477 | Cite as

Comparative study of the efficacy and safety of Aceclofenac and Tenoxicam in rheumatoid arthritis

  • F. Perez-Ruiz
  • A. Alonso-Ruiz
  • J. J. Ansoleaga


To compare the efficacy and safety of aceclofenac (AC) and tenoxicam (TX) in the treatment of rheumatoid arthritis (RA), a multicentric parallel, randomized, double-blind trial of three months duration was performed in 292 patients: 145 were randomized to the AC treatment group and 147 to the TX treatment group. The trial was completed by 237 (81.1%) patients. Both treatment groups showed amelioration of clinical parameters monitored at 15 days, and this improvement continued until the end of the trial, no statistically significant differences being observed between AC and TX. Twenty-four patients (8.2%, 12 AC and 12 TX) did not complete the trial because of inefficacy, and 15 because of side effects (5.1%, 6 AC and 9 TX), in 7 of them due to gastrointestinal intolerance (2,4%, 1 AC, 6 TX, p=0.052). These data demonstrate that AC shows similar efficacy to TX in the treatment of rheumatoid arthritis and better safety profile than TX, mainly regarding gastrointestinal tolerability.

Key words

Aceclofenac Tenoxicam Rheumatoid Arthritis NSAID 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    American Rheumatism Association Cooperating Clinics Committee: Aspirin in rheumatoid arthritis: a seven-day double-blind trial preliminary report. Bull Rheum Dis 1965, 16, 338.Google Scholar
  2. 2.
    Grau, M., Guasch, J., Montero, L., Felipe, A., Garrasco, E., Julia, S. Pharmacology of the potent new monsteroidal antiinflammatory agent aceclofenac. Arzneim Forsch Drug Res 1991, 41, 1265–1276.Google Scholar
  3. 3.
    Grau, M., Montero, J.L., Guasch, J., Felipe, A., Carrasco, E., Julia, S. The pharmacological profile of aceclofenac, a new non-steroid antiinflammatory and analgesic drug. Agent Actions. Suppl 1991, 129.Google Scholar
  4. 4.
    Ballesteros, R., Ansoleaga, J.J., Tapounet, R. The efficacy and tolerance of aceclofenac in rheumatoid arthritis. Clin Trials J 1990, 27, 12–19.Google Scholar
  5. 5.
    Diaz, C., Rodriguez, A., Geli, C., Llobet, J.M., Tapounet, R. Comparison of aceclofenac and diclofenac in osteoarthritic pain. Curr Ther Res 1988, 44, 252–256.Google Scholar
  6. 6.
    Caughey, D., Waterworth, R.F. A study in the safety of tenoxicam in general practice: N Z Med J 1989, 102, 582–583.PubMedGoogle Scholar
  7. 7.
    Simpson, J., Golding, D.N., Freeman, A.M., Cooke, D., Hooper, P.A., Jamieson, V., Osborne, C. A large, multicentre, parallel group, double-blind study comparing tenoxicam and piroxicam in the treatment of osteoarthritis and rheumatoid arthritis. Br J Clin Pract 1989, 43, 328–333.PubMedGoogle Scholar
  8. 8.
    Atkinson, M., Kahna, V., Ménard, H., Russel, S., Tannenbaum, H. A comparison of tenoxicam and piroxicam in the treatment of rheumatoid arthritis. J Rheumatol 1991, 19, 538–42.Google Scholar
  9. 9.
    Carne, X., Moreno, V., Porta Serra, M. Velilla, E. Calculating the number of patients necessary for designing a clinical study. Med Clin (Barc) 1989, 72, 72–77.Google Scholar
  10. 10.
    Arnett, F.G., Edworthy, S.M., Bloch, D.A., McShane, D.J., Fries, J.F., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31, 315–324.PubMedGoogle Scholar
  11. 11.
    Ritchie, D.M., Boyle, J.A., McInnes, J.M., Jasani, M.K., Dalakos, T.G., Grieveson, P., Buchanan, W.W. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritís. Q Med J 1968, 37, 393–406.Google Scholar
  12. 12.
    Sandoval, D.M., Alarcon, G.S., Morgan, S.L. Adverse events in methotrexate-treated rheumatoid arthritis patients. Br J Rheumatol 1995, 34 (suppl 2), 49–56.PubMedGoogle Scholar

Copyright information

© Clinical Rheumatology 1996

Authors and Affiliations

  • F. Perez-Ruiz
    • 1
  • A. Alonso-Ruiz
    • 1
  • J. J. Ansoleaga
    • 2
  1. 1.Rheumatology SectionHospital de CrucesVizcaya
  2. 2.Medical Department of Prodesfarma Research CenterBarcelonaSpain

Personalised recommendations